PubRank

R L Priore

Author PubWeight™ 54.95‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) Ann Neurol 1996 10.39
2 Cellular differentiation of the immune system of mice. I. Separate splenic antigen-sensitive units for different types of anti-sheep antibody-forming cells. J Exp Med 1968 2.51
3 Thromboembolism prophylaxis in chronic atrial fibrillation. Practice patterns in community and tertiary-care hospitals. Stroke 1997 1.89
4 Correlation of clinical, magnetic resonance imaging, and cerebrospinal fluid findings in optic neuritis. Ann Neurol 1997 1.55
5 Diet and alcohol consumption and lung cancer risk in the New York State Cohort (United States) Cancer Causes Control 1997 1.51
6 Cellular differentiation of the immune system of mice. V. Class differentiation in marrow precursors of plaque-forming cells. J Exp Med 1969 1.50
7 Neuropsychological effects of interferon beta-1a in relapsing multiple sclerosis. Multiple Sclerosis Collaborative Research Group. Ann Neurol 2000 1.39
8 Rapid assay of murine leukemia virus helper activity for Friend spleen focus-forming virus. J Natl Cancer Inst 1971 1.37
9 Test-retest reliability of the cognitive lifetime drinking history. Am J Epidemiol 1997 1.32
10 Cellular differentiation of the immune system of mice. IV. Lack of class differentiation in thymic antigen-reactive cells. J Exp Med 1969 1.31
11 Cellular differentiation of the immune system of mice. II. Frequency of unipotent splenic antigen-sensitive units after immunization with sheep erythrocytes. J Exp Med 1969 1.26
12 The binding of tranexamic acid to native (Glu) and modified (Lys) human plasminogen and its effect on conformation. J Biol Chem 1979 1.19
13 Brain MRI lesions and atrophy are related to depression in multiple sclerosis. Neuroreport 2000 1.15
14 Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG). Neurology 1997 1.14
15 Information in natural languages. A new approach. JAMA 1969 1.13
16 Prospective evaluation of the Ottawa Ankle Rules in a university sports medicine center. With a modification to increase specificity for identifying malleolar fractures. Am J Sports Med 1998 1.12
17 Antibiotic use, hospital admissions, and mortality before and after implementing guidelines for nursing home-acquired pneumonia. J Am Geriatr Soc 2001 1.06
18 A statistical method for the estimation of binding parameters in a complex system. Anal Biochem 1976 1.03
19 Cerebrospinal fluid abnormalities in a phase III trial of Avonex (IFNbeta-1a) for relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group. J Neuroimmunol 1999 1.00
20 Personality disorder in multiple sclerosis correlates with cognitive impairment. J Neuropsychiatry Clin Neurosci 2001 0.96
21 Prognostic factors in patients with advanced stage prostate cancer. Cancer Res 1985 0.96
22 Relative reliability of five serially measured markers for prognosis of progression in prostate cancer. J Natl Cancer Inst 1986 0.96
23 Treatment of advanced ovarian carcinoma in the elderly. Gynecol Oncol 1993 0.93
24 A genetic analysis of melanoma--polygenic inheritance as a threshold trait. Am J Epidemiol 1981 0.90
25 The Ordac method of making age adjustments in data. J Chronic Dis 1964 0.87
26 Capsular polysaccharide and O-specific antigen divergently modulate pulmonary neutrophil influx in an Escherichia coli model of gram-negative pneumonitis in rats. Infect Immun 2000 0.86
27 Hormone-refractory metastatic prostatic cancer treated with methotrexate, cyclophosphamide plus adriamycin, cis-platinum plus 5-fluorouracil plus cyclophosphamide. National Prostatic Cancer Project randomized trial. Urology 1988 0.85
28 Cigarette smoking and periodontal disease. J Am Dent Assoc 1968 0.84
29 Recognition of drug resistance during remission induction therapy for acute non-lymphocytic leukemia: utility of day 6 bone marrow biopsy. Leuk Res 1983 0.83
30 Prostatic cancer. Treated at a categorical center, 1980-1983. Urology 1986 0.82
31 Effect of immunization with common enterobacterial antigen on experimental Salmonella typhimurium infection of mice. Immunol Commun 1972 0.82
32 Relationship between leukemic cell retention of cytosine arabinoside triphosphate and the duration of remission in patients with acute non-lymphocytic leukemia. Eur J Cancer Clin Oncol 1985 0.81
33 Comparability of nutrient estimation by three food frequency questionnaires for use in epidemiological studies. Nutr Cancer 1999 0.80
34 Using a mathematical model in the evaluation of human tumor response to chemotherapy. J Natl Cancer Inst 1966 0.80
35 ROSFIT: an enzyme kinetics nonlinear regression curve fitting package for a microcomputer. Comput Biomed Res 1982 0.79
36 Comparing the ability of various compositive outcomes to discriminate treatment effects in MS clinical trials. The Multiple Sclerosis Collaborative Research Group (MSCRG). Mult Scler 1998 0.79
37 Screening for atrial fibrillation in the community: a multicenter validation trial. J Stroke Cerebrovasc Dis 2007 0.78
38 Statistical analysis of data from countercurrent distribution. 3. The biliary and urinary excretion patterns of estriol in a human subject. Steroids 1968 0.78
39 Statistical analysis of data from countercurrent distribution. II. Some applications and limitations of the method. Anal Biochem 1968 0.78
40 Statistical analysis of data from countercurrent distribution. I. Method for estimation of quantity and partition coefficient of each compound in the distribution. Anal Biochem 1968 0.77
41 Mechanism(S) of interferon inhibitory activity in blood from patients with AIDS and patients with lupus erythematosus with vasculitis. Res Commun Mol Pathol Pharmacol 1997 0.76
42 Impact of interferon beta-1a on neurologic disability in relapsing multiple sclerosis. 1997. Neurology 2001 0.76
43 Postoperative respiratory complications in patients with Hodgkin's disease: relationship to the size of the mediastinal tumor. Eur J Cancer Clin Oncol 1985 0.76
44 Prostate cancer mortality among Catholic priests. J Surg Oncol 1981 0.75
45 A comparison of estrogen and androgen receptor levels in human prostatic tissue from patients with non-metastatic and metastatic carcinoma and benign prostatic hyperplasia. J Steroid Biochem 1985 0.75
46 Bombesin antagonist prevents CO2 laser-induced promotion of oral cancer. Proc Natl Acad Sci U S A 1996 0.75
47 Systemization of scatchard or Lineweaver-Burk plot linearization: application to receptor analysis. Prog Clin Biol Res 1979 0.75
48 The clonogenic assay as a reproducible in vitro system to study predictive parameters of treatment outcome in acute nonlymphoblastic leukemia. Am J Hematol 1983 0.75
49 Antitumor activity of Corynebacterium parvum and retinyl palmitate used in combination on the Lewis lung carcinoma. Cancer Res 1980 0.75
50 Skin pressure measurements on various mattress surfaces in cancer patients. Am J Phys Med 1983 0.75
51 Epidemiology of survival from cancer of the cervix. J Natl Cancer Inst 1972 0.75
52 Feasibility of automated information systems in the users' natural language. Am Sci 1969 0.75
53 U.S. centralized cancer patient data system for uniform communication among cancer centers. J Natl Cancer Inst 1981 0.75
54 Statistical analysis of data from countercurrent distribution. V. The isotope effect. Anal Biochem 1970 0.75
55 Statistical analysis of data from Countercurrent distribution. IV. Identification of compounds. Anal Biochem 1970 0.75
56 Experience with the use of generalized data base management systems in cooperative group clinical trials (a project of the Gynecologic Oncology Group). Control Clin Trials 1987 0.75
57 Cancer of the tongue. Comments on surgical treatment. Am J Surg 1966 0.75
58 Automated multiphasic laboratory screening in cancer population. N Y State J Med 1972 0.75
59 Phase I trial and pharmacokinetics of a daily x 5 schedule of 3-deazauridine. Cancer Treat Rep 1982 0.75
60 Carcinogenic activity of smoke condensate from cigarettes with ammonium sulfamate-treated paper. Cancer 1974 0.75